Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the safety and efficacy of testosterone 0.03%
ophthalmic solution compared to vehicle for the treatment of meibomian gland dysfunction.